Down's syndrome and maternal cancer. A preliminary study
- PMID: 2964249
- DOI: 10.1111/j.1699-0463.1988.tb05285.x
Down's syndrome and maternal cancer. A preliminary study
Abstract
The possible association between maternal cancer and Down's syndrome was studied in a register-based case-control study of 962 women who had an infant with Down's syndrome born during 1973-1981, and to each two controls, matched for maternal age, parity, and year of delivery. A total of 952 complete triplets was obtained. Among them, 63 Down's syndrome mothers and 79 control mothers were found in a cancer registry for the period 1958-1982 (odds ratio 1.6;95% conf. interval 1.3-2.0). Of these, 14 Down's syndrome mothers and 20 controls had malignant lesions (odds ratio 1.4, 0.9-2.2), and 49 Down's syndrome mothers and 55 controls had cervical cancer in situ (odds ratio 1.8, 1.4-2.3). This risk increase was present both before and after the delivery of the Down's syndrome infant. Various explanations of these findings are discussed and the need for further data is stressed.
Similar articles
-
Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.Nutrition. 2005 Jun;21(6):698-704; discussion 774. doi: 10.1016/j.nut.2004.10.017. Nutrition. 2005. PMID: 15925294
-
Investigation of a cluster of children with Down's syndrome born to mothers who had attended a school in Dundalk, Ireland.Occup Environ Med. 2000 Dec;57(12):793-804. doi: 10.1136/oem.57.12.793. Occup Environ Med. 2000. PMID: 11077007 Free PMC article.
-
Parity and the risk of Down's syndrome.Am J Epidemiol. 2003 Sep 15;158(6):503-8. doi: 10.1093/aje/kwg193. Am J Epidemiol. 2003. PMID: 12965874
-
Epidemiology of trisomy 21: population, peri- and antenatal data.Hum Genet Suppl. 1981;2:211-26. doi: 10.1007/978-3-642-68006-9_16. Hum Genet Suppl. 1981. PMID: 6218137 Review.
-
Maternal serum markers for Down's syndrome pregnancies.Singapore Med J. 1995 Aug;36(4):417-23. Singapore Med J. 1995. PMID: 8919160 Review.
Cited by
-
Selective advantage of fra (X) heterozygotes compared with mothers of Down syndrome probands?Hum Genet. 1992 Mar;88(5):599-601. doi: 10.1007/BF00219354. Hum Genet. 1992. PMID: 1532372 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical